Skip to main content
BioPlus Co., Ltd logo

BioPlus Co., Ltd — Investor Relations & Filings

Ticker · 099430 ISIN · KR7099430001 KO Manufacturing
Open in API
Filings indexed 226 across all filing types
Latest filing 2024-07-10 Report Publication Anno…
Country KR South Korea
Listing KO 099430

About BioPlus Co., Ltd

https://ubioplus.com/

BioPlus Co., Ltd. is a company that researches, develops, and manufactures biomaterials, with a primary focus on hyaluronic acid (HA) applications. The company's core competency is its proprietary MDM® Technology, which is used to create a diverse product portfolio for the beauty and healthcare industries. Key products include a range of dermal and body fillers, skin boosters, anti-adhesion agents, biomaterial breast implants, and artificial cartilage. The company aims to provide bio-therapy solutions by addressing fundamental cellular-level issues through its advanced technologies.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a short announcement (868 characters) regarding the scheduling of an Investor Relations (IR) event (Non-Deal Roadshow). It provides the date, location, and purpose of the meeting, and mentions that the actual IR materials will be posted on the Korea Exchange (KIND) system at a later date. Since this is an announcement of an event and not the presentation itself, and it does not fit into specific categories like 'Call Transcript' or 'Annual Report', it is classified as a Regulatory Filing (RNS) as it serves as a formal notice of corporate activity.
2024-07-10 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding the scheduling and details of an Investor Relations (IR) event (Non-Deal Roadshow). It specifies the date, location, target audience, and purpose of the meeting. Since it is an announcement of an upcoming event rather than the presentation materials themselves, and it serves as a regulatory notification of corporate activity, it fits best under the 'Regulatory Filings' category as it does not contain the actual financial presentation content.
2024-07-10 Korean
기타시장안내 (업종변경 안내)
Regulatory Filings Classification · 100% confidence The document is a short announcement from Bioplus regarding a change in its industry classification code due to a revision in the Korean Standard Industrial Classification. It is a regulatory notification issued to the market via the Korea Exchange. Since it does not fit into specific categories like financial reports, dividends, or M&A, and serves as a general regulatory update, it is classified as a Regulatory Filing (RNS).
2024-06-28 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed in accordance with Article 147 of the Capital Markets Act in South Korea. This type of filing is used to disclose significant changes in share ownership by major shareholders or insiders. In the provided taxonomy, this falls under 'Major Shareholding Notification' (MRQ), which covers notifications of changes in significant share ownership levels.
2024-06-12 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by a director (Jung Hyun Kyu) of BioPlus Co., Ltd. It details specific share transactions (purchases) made by an insider. This corresponds to the 'Director's Dealing' category, which covers personal share transactions by company directors and executives.
2024-06-12 Korean
주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean Financial Supervisory Service/Korea Exchange. It specifically details the company's decision to enter into a trust agreement for the acquisition of its own shares (자기주식취득 신탁계약 체결 결정). This falls under the category of a company buying back its own shares, which is classified as 'Transaction in Own Shares' (POS).
2024-06-10 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.